Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	CASE_CONTROL	Chemotherapy	Drug	Race	TIMEPOINT	Tamoxyfen	Taxane
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	1698	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	1964	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	2654	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	3130	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	3174	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	3369	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	3468	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	3490	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	3534	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	3541	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	3791	Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	4010	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	4026	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	4129	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	4130	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	4282	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	4342	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	4409	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	4456	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	4548	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	4573	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	4587	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	4717	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	4746	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	4749	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	4816	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	4818	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	4999	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	5128	Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	5134	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	5134	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	5271	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	5283	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	5287	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	5373	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	5629	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	5689	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	5690	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	5698	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	5723	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	5727	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	5748	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	5778	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	5782	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	5842	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	5858	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	5903	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	5939	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	5981	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	6044	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	6088	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	6108	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	6155	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	6272	Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	6433	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	6442	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	6542	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	6544	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	6665	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	6764	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	6868	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	6932	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	6987	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	7031	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	7171	Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	7276	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	7302	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	7344	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	7553	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	7705	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	7742	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	7895	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	7967	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	7969	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	8081	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	8317	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	8356	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	8388	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	8727	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	8743	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	9053	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	9288	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	9678	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	9813	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	10282	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	11457	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-	18901	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-		Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-		Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-		Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-		Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-		Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-		Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-		Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-		Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-		Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-		Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-		Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-		Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M-H)-		Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]	1078	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]	1111	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]	1399	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]	1679	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]	2171	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]	2271	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]	3404	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]	3582	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]	3755	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+H)+[-H2O]		Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	1055	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	1488	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	2232	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	2639	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	4161	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	6706	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	8976	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	9904	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	10662	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	11625	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	13216	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	13480	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	14095	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	14508	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	14593	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	14602	Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	14957	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	14974	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	15432	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	16585	Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	16649	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	16743	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	17094	Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	17587	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	18363	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	18964	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	19075	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	19989	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	21088	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	21213	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	21842	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	22291	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	22439	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	22784	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	22832	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	23147	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	23295	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	23752	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	24953	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	25382	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	25427	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	26583	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	26654	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	26784	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	27391	Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	AZELAIC ACID (CAS# 123-99-9); (M+NA)+	27940	Peak area	Case	Y	Exemestane	White	3 Month	Y	N

Return to search page